A similar mechanism has been proposed in lung adenocarcinoma, where FBLN2 can facilitate the development of the new ECM surrounding tumor cells, perhaps originating from tumor-associated fibroblasts [71]. The gene discussed is FBLN2; the disease is neoplasm.